These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32187162)

  • 1. Fluoro-deoxy-glucose uptake in the mylohyoid muscle: a common misconception.
    Pizzuto DA; Husmann L; Stolzmann P; Meerwein C; Orita E; von Schulthess GK; Huellner MW
    Nucl Med Commun; 2020 May; 41(5):452-458. PubMed ID: 32187162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [18F]Fluorodeoxyglucose-PET/CT differentiation between physiological and pathological accumulations in head and neck.
    Nakamura S; Okochi K; Murata Y; Shibuya H; Kurabayashi T
    Nucl Med Commun; 2009 Jul; 30(7):498-503. PubMed ID: 19434008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoas muscle fluorine-18-labelled fluoro-2-deoxy-d-glucose uptake associated with the incidence of existing and incipient metabolic derangement.
    Kim JY; Jun DW; Choi J; Nam E; Son D; Choi YY
    J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):894-902. PubMed ID: 31094095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
    Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
    Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal FDG distribution patterns in the head and neck: PET/CT evaluation.
    Nakamoto Y; Tatsumi M; Hammoud D; Cohade C; Osman MM; Wahl RL
    Radiology; 2005 Mar; 234(3):879-85. PubMed ID: 15734938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management.
    Basu S; Houseni M; Alavi A
    Nucl Med Commun; 2008 Apr; 29(4):367-73. PubMed ID: 18317302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologic [18F]fluorodeoxyglucose uptake of floor of mouth muscles in PET/CT imaging: a problem of body position during FDG uptake?
    Haerle SK; Hany TF; Ahmad N; Burger I; Huber GF; Schmid DT
    Cancer Imaging; 2013 Feb; 13(1):1-7. PubMed ID: 23425816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
    Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
    J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary analysis: Background parenchymal 18F-FDG uptake in breast cancer patients appears to correlate with background parenchymal enhancement and to vary by distance from the index cancer.
    Kim E; Mema E; Axelrod D; Sigmund E; Kim SG; Babb J; Melsaether AN
    Eur J Radiol; 2019 Jan; 110():163-168. PubMed ID: 30599855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
    Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
    Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of FDG uptake in early stage non-small cell lung cancer.
    Hanin FX; Lonneux M; Cornet J; Noirhomme P; Coulon C; Distexhe J; Poncelet AJ
    Eur J Cardiothorac Surg; 2008 May; 33(5):819-23. PubMed ID: 18374589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous whole-body time-of-flight 18F-FDG PET/MRI: a pilot study comparing SUVmax with PET/CT and assessment of MR image quality.
    Iagaru A; Mittra E; Minamimoto R; Jamali M; Levin C; Quon A; Gold G; Herfkens R; Vasanawala S; Gambhir SS; Zaharchuk G
    Clin Nucl Med; 2015 Jan; 40(1):1-8. PubMed ID: 25489952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A stepwise approach using metabolic volume and SUVmax to differentiate malignancy and dysplasia from benign colonic uptakes on 18F-FDG PET/CT.
    Oh JR; Min JJ; Song HC; Chong A; Kim GE; Choi C; Seo JH; Bom HS
    Clin Nucl Med; 2012 Jun; 37(6):e134-40. PubMed ID: 22614211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer.
    Calais J; Dubray B; Nkhali L; Thureau S; Lemarignier C; Modzelewski R; Gardin I; Di Fiore F; Michel P; Vera P
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):858-67. PubMed ID: 25680400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of MRI and FDG-PET/CT to predict fixation of advanced hypopharyngeal squamous cell carcinoma to prevertebral space.
    Meerwein CM; Pizzuto DA; Vital D; Morand GB; Stolzmann P; Huber GF; Huellner MW
    Head Neck; 2019 Feb; 41(2):503-510. PubMed ID: 30561113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
    Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
    Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of (18)F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR.
    Rasmussen JH; Fischer BM; Aznar MC; Hansen AE; Vogelius IR; Löfgren J; Andersen FL; Loft A; Kjaer A; Højgaard L; Specht L
    Br J Radiol; 2015 Apr; 88(1048):20140655. PubMed ID: 25634069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of F-18 FDG PET/CT in assessing IgG4-related disease with inflammation of head and neck glands.
    Tokue A; Higuchi T; Arisaka Y; Nakajima T; Tokue H; Tsushima Y
    Ann Nucl Med; 2015 Jul; 29(6):499-505. PubMed ID: 25877159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.